Any vaccine to fight the new coronavirus will not be ready for use for at least two years, the chief executive of Swiss pharmaceutical company Novartis, which no longer makes vaccines itself, told a German newspaper.
Novartis sold its vaccine business in 2015 to GlaxoSmithKline, one of many companies around the world now racing to make a drug. Some companies are already testing vaccine candidates on humans.
For instance, Moderna Inc has sped up plans for its experimental COVID-19 vaccine and said it expected to start a late-stage trial in early summer. [nL1N2CP13A]
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Red Arrow’s Bo Stehmeier Rejoins Off The Fence as Co-CEOBo Stehmeier, president of distributor Red Arrow Studios International, has been appointed joint-CEO of ZDF Enterprises-owned producer and distributor Off the Fence, alongside company founder Ellen…
Read more »
AT&T’s CEO Steps Down With A $64 Million Gold-Plated Retirement PlanAT&T CEO Randall Stephenson announced at the end of April that he’s stepping down. Stephenson said that he’ll serve in the capacity of executive chairman of AT&T’s board up until January 2021. Stephenson was a long-term company man.
Read more »
BCG CEO on how the pandemic will impact the consulting industry - Business InsiderRich Lesser says firms need to think about how they can achieve the same level of efficiency working with clients remotely.
Read more »
New membership sign-ups 'on par' with last year, Planet Fitness CEO says'[I'm] really encouraged by what I'm seeing,' Planet Fitness CEO Chris Rondeau said as the budget gym chain reopens locations.
Read more »
Airline industry not likely to recover for at least a year: Southwest CEOThe airline industry is not likely to recover to pre-coronavirus levels for at least the next six to 12 months, Southwest Airlines Co Chief Executive Officer Gary Kelly said on Thursday.
Read more »
Stocks Slump, 36 Million Jobs Lost, Vaccine in 2021?, AbbVie CEO by Squawk on the Street
Read more »